Scala Biodesign Ltd. (Scala Bio)

www.scala-bio.com

High-Tech Company

TECH VERTICALS

Analysis, Artificial Intelligence, Biotechnology, FoodTech, Optimization, Protein, Software Technologies

General Data

Sector	Enterprise Software & Infrastructure
Company Stage:	R&D
Established	2022
Number of Employees	10
Reg. Number:	abCDe

DESCRIPTION

Scala is developing a computational platform for protein engineering, which allows companies to significantly reduce the costs and duration of development of protein-based products or processes and enable them to develop products. Scala's technologies make the protein engineering process faster and cheaper and significantly increase its success rates. The company symbolizes the process on the computer and selects the most suitable chemical changes, thus allows its customers to engineer proteins in a more efficient and better way and on a large scale.

TECHNOLOGY

Scala provide a unique one-shot computational solution that accelerates the development of proteins into commercial products. The company technology combines evolutionary analysis, atomistic protein design calculations and AI to design proteins with better properties, which can be used in the pharmaceutical, chemical and sustainability industries to develop commercial products faster and more effectively.

	TARGET MARKETS
	Pharmaceutical, Chemical and Sustainability industries.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	18 Yosef Karo St.
City	Tel Aviv
Country	Israel
Zip	6701422

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Ravit Netzer	CEO & Co-Founder
Dr. Adi Goldenzweig	CTO & Co-Founder
Prof. Sarel Fleishman	Chief Scientist

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Observer	VP, Business Development, Yeda

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Jul. 26, 2022

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Consulting Firm	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Nov. 09, 2022

R&D

Contributor	Type	Amount	Remarks
abC Defghij	Corporate Accelerator	abCDe

Last Updated:	abCDe
IVC Number:	abCDe